Abstract
The Japan Society of Clinical Oncology (JSCO) published the “JSCO Clinical Practice Guidelines 2017 for Fertility Preservation in Childhood, Adolescent, and Young Adult Cancer Patients” in 2017. This was the first guideline in cancer reproductive medicine in Japan. In the field of cancer reproductive medicine, close cooperation between an oncologist and a physician for reproductive medicine is important from before treatment initiation until long after treatment. The guideline takes into consideration disease specificity and provides opinions from the perspective of oncologists and specialists in reproductive medicine that are in line with the current state of the Japanese medical system. It is intended to serve as a reference for medical staff in both fields regarding the availability of fertility preservation therapy before the start of cancer treatment. Appropriate use of this guideline makes it easier to determine whether fertility preservation therapy is feasible and, ultimately, to improve survivorship in childhood, adolescent, and young adult cancer patients. In this article (Part 2), we describe details by organ/system and also for pediatric cancer.
Highlights
We present Part 2 of the Japanese Society of Clinical Oncology (JSCO) Clinical Practice Guidelines 2017 for Fertility Preservation in Childhood, Adolescent, and Young Adult (CAYA) Cancer Patients
According to the Patient Annual Report for Fiscal Year 2010 issued by the Japan Society of Obstetrics and Gynecology (JSOG) Gynecological Oncology Committee, the number of patients with stage IA1 to IB1 cervical cancer who were younger than 40 years of age was estimated to be 1105, and these patients were estimated to account for 33% of all patients with cervical cancer at these stages [2]
The clinical stages referred to in this clinical question (CQ) were assigned according to the JSOG 2011/International Federation of Gynecology and Obstetrics (FIGO) 2008 cervical cancer staging criteria, which are presented in Japanese in the General Rules for Clinical and Pathological Management of Uterine Cervical Cancer, 3rd edition [3]
Summary
We present Part 2 of the Japanese Society of Clinical Oncology (JSCO) Clinical Practice Guidelines 2017 for Fertility Preservation in Childhood, Adolescent, and Young Adult (CAYA) Cancer Patients. According to the Patient Annual Report for Fiscal Year 2010 issued by the Japan Society of Obstetrics and Gynecology (JSOG) Gynecological Oncology Committee, the number of patients with stage IA1 to IB1 cervical cancer who were younger than 40 years of age was estimated to be 1105, and these patients were estimated to account for 33% of all patients with cervical cancer at these stages [2] To answer this clinical question (CQ), we discussed which patients with cervical cancer are eligible for conservative surgery (trachelectomy) on the assumption that the pathological diagnosis and staging of the malignancy are accurate. The clinical stages referred to in this CQ were assigned according to the JSOG 2011/International Federation of Gynecology and Obstetrics (FIGO) 2008 cervical cancer staging criteria, which are presented in Japanese in the General Rules for Clinical and Pathological Management of Uterine Cervical Cancer, 3rd edition [3]
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
